Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (546)	10/29/2001 8:46:09 PM
From: Miljenko Zuanic	Respond to of 1169

SOURCE: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Announces the Appointment of Ian F. Smith as Vice President and Chief Financial Officer CAMBRIDGE, Mass., Oct. 29 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - news) announced today that it has named Ian F. Smith to the newly created position of Chief Financial Officer. Mr. Smith joins Vertex from the accounting firm Ernst & Young LLP, where he served as a partner in their Life Science and Technology Practice. <snip> Accountant to practice bio-business! Give me a break. They are loosing credibility almost by every step. <<Mr. Smith has focused his practice ...>> What did he achieve, not where he is focused? Miljenko